Fluorescence-Guided Raman Spectroscopy for Tumour Margin Delineation
Authors:
Conor C. Horgan,
Mads S. Bergholt,
May Zaw Thin,
Anika Nagelkerke,
Robert Kennedy,
Tammy L. Kalber,
Daniel J. Stuckey,
Molly M. Stevens
Abstract:
The initial detection and identification of suspicious lesions and the precise delineation of tumour mar-gins are essential for successful tumour resection, with progression-free survival linked to rates of complete resection. However, post-surgical positive margin rates remain high for many cancers and despite numerous advances in intraoperative imaging and diagnostic technologies, there exists n…
▽ More
The initial detection and identification of suspicious lesions and the precise delineation of tumour mar-gins are essential for successful tumour resection, with progression-free survival linked to rates of complete resection. However, post-surgical positive margin rates remain high for many cancers and despite numerous advances in intraoperative imaging and diagnostic technologies, there exists no single modality that can adequately perform both tumoural detection and delineation. Here, we demonstrate a multimodal computer vision-based diagnostic system capable of both the gross detection and identification of suspicious lesions and the precise delineation of disease margins. We first show that through visual tracking of a spectroscopic probe, we enable real-time tumour margin delineation both for ex vivo human tumour biopsies and for an in vivo tumour xenograft mouse model. We then demonstrate that the combination of Raman spectroscopic diagnoses with protoporphyrin IX (PPIX) fluorescence imaging enables fluorescence-guided Raman spectroscopic margin delineation. Our fluorescence-guided Raman spectroscopic system achieves superior margin delineation accuracy to fluorescence imaging alone, demonstrating the potential for our system to achieve improved clinical outcomes for tumour resection surgeries.
△ Less
Submitted 24 September, 2020;
originally announced September 2020.
Integrated Photodynamic Raman Theranostics for Cancer Diagnosis, Treatment, and Post-Treatment Molecular Monitoring
Authors:
Conor C. Horgan,
Mads S. Bergholt,
Anika Nagelkerke,
May Zaw Thin,
Isaac J. Pence,
Ulrike Kauscher,
Tammy L. Kalber,
Daniel J. Stuckey,
Molly M. Stevens
Abstract:
Theranostics, the combination of diagnosis and therapy, has long held promise as a means to achieving personalised precision cancer treatments. However, despite its potential, theranostics has yet to realise significant clinical translation, largely due the complexity and overriding toxicity concerns of existing theranostic nanoparticle strategies. Here, we present an alternative nanoparticle-free…
▽ More
Theranostics, the combination of diagnosis and therapy, has long held promise as a means to achieving personalised precision cancer treatments. However, despite its potential, theranostics has yet to realise significant clinical translation, largely due the complexity and overriding toxicity concerns of existing theranostic nanoparticle strategies. Here, we present an alternative nanoparticle-free theranostic approach based on simultaneous Raman spectroscopy and photodynamic therapy (PDT) in an integrated clinical platform for cancer theranostics. We detail the compatibility of Raman spectroscopy and PDT for cancer theranostics, whereby Raman spectroscopic diagnosis can be performed on PDT photosensitiser-positive cells and tissues without inadvertent photosensitiser activation/photobleaching or impaired diagnostic capacity. We further demonstrate that our theranostic platform enables in vivo tumour diagnosis, treatment, and post-treatment molecular monitoring in real-time. This system thus achieves effective theranostic performance, providing a promising new avenue towards the clinical realisation of theranostics.
△ Less
Submitted 8 September, 2020;
originally announced September 2020.
